UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046760
Receipt number R000049920
Scientific Title Analysis of sweat gland function after sweating load in healthy subjects
Date of disclosure of the study information 2022/01/31
Last modified on 2024/08/21 14:01:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of sweat gland function after sweating load in healthy subjects

Acronym

Analysis of sweat gland function after sweating load in healthy subjects

Scientific Title

Analysis of sweat gland function after sweating load in healthy subjects

Scientific Title:Acronym

Analysis of sweat gland function after sweating load in healthy subjects

Region

Japan


Condition

Condition

healthy subject
an/hypohidrosis

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to analyze sweat gland function by histological and molecular biological methods using skin tissues collected from healthy individuals before and after sweating induction.

Basic objectives2

Others

Basic objectives -Others

The secondary purpose in to examine the pathological significance of sweat leakage into the dermis.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Histological (HE staining, immunostaining, etc.) and molecular biological (PCR, in-situ hybridization, etc.) methods will be used to analyze the histological characteristics, proteins, and gene expression of the collected healthy human skin sections before and after sweating induction.

Key secondary outcomes

Histological characteristics, proteins, and gene expression of collected healthy human skin sections before and after sweat induction will be compared with tissue sections from skin disease patients (after sweat loading) and existing normal skin tissue sections (without sweat loading).


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

First, skin samples are taken from either the left or right side of the abdomen before heat loading. Next, the other side of the abdomen is used to identify the sweating site using the starch-iodine method. Skin tissue is collected from the identified sweating site. The wound is sutured as appropriate and the stitches are removed after 7 days. The collected tissue should be evaluated using an appropriate method.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

35 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Those who are at the age from 20 to 35 years old at the time of obtaining consent.
2. Those who can obtain written consent for participation in this study.

Key exclusion criteria

1. Those who are judged inappropriate by the principal investigator or sub-investigators.
2. Patients with cholinergic urticaria, atopic dermatitis, anhidrosis, hyperhidrosis, and those with a history of such conditions, as well as patients with other skin diseases that may affect the study and those with a history of such conditions.
3. Patients who are taking drugs that affect sweating, such as drugs with anticholinergic effects.
4. Persons with a history of allergy to xylocaine, cefcapene pivoxil hydrochloride hydrate, or loxoprofen.
5. Persons with hypersensitivity to iodine, ethanol, or corn.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Shunsuke
Middle name
Last name Takahagi

Organization

Hiroshima University

Division name

Dermatology

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima Prefecture

TEL

082-257-5238

Email

shunstk@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Nozomi
Middle name
Last name Yanagida

Organization

Hiroshima University

Division name

Dermatology

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima Prefecture

TEL

082-257-5238

Homepage URL


Email

nonzyma@gmail.com


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee for Epidemiology of Hiroshima University

Address

1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima Prefecture

Tel

082-257-5831

Email

iryo-seisaku@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 31 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2022 Year 01 Month 20 Day

Date of IRB

2022 Year 01 Month 20 Day

Anticipated trial start date

2022 Year 01 Month 20 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 01 Month 28 Day

Last modified on

2024 Year 08 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049920